NOTCH3 and ovarian cancer: We have previously demonstrated that Notch3-specific inhibition by Notch3 specific siRNA and γ-secretase inhibitor (GSI) sensitizes PTX-resistant ovarian cancer cells to paclitaxel treatment [5].